Skip to main content
. 2020 Oct 9;35(3):1230–1236. doi: 10.1002/ptr.6887

FIGURE 2.

FIGURE 2

A reasonable target for structure‐based drug discovery was identified to be the disruption of the viral S protein‐ACE2 receptor interface. Rendering of nCoV‐2019 S‐protein and ACE2 receptor. Green represents the interface targeted for docking. Source: Smith and Smith (2020), ChemRxiv [Colour figure can be viewed at wileyonlinelibrary.com]